Is Biolase Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: BIOL) stock is to Buy BIOL stock.
Out of 2 analysts, 0 (0%) are recommending BIOL as a Strong Buy, 2 (100%) are recommending BIOL as a Buy, 0 (0%) are recommending BIOL as a Hold, 0 (0%) are recommending BIOL as a Sell, and 0 (0%) are recommending BIOL as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year BIOL price target, the average BIOL price target is $2.20, with the highest BIOL stock price forecast at $4.00 and the lowest BIOL stock price forecast at $0.40.
On average, Wall Street analysts predict that Biolase's share price could reach $2.20 by Apr 1, 2025. The average Biolase stock price prediction forecasts a potential upside of 1,386.49% from the current BIOL share price of $0.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.